Immune cells from your own tumor could fight cervical cancer
NCT ID NCT06241781
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new treatment called GT101, which uses immune cells taken from a patient's own tumor to fight recurrent or metastatic cervical cancer. About 83 adults will receive either GT101 or a standard chemotherapy drug. The goal is to see if the cell therapy can delay cancer growth better than standard treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADULT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Affiliated Zhongshan Hospital Dalian University
RECRUITINGDalian, Liaoning, 116001, China
-
Chinese Academy of Medical Sciences Cancer Hospital Shenzhen Hospital
RECRUITINGShenzhen, Guangdong, 518172, China
-
Dalian Medical University First Affiliated Hospital
RECRUITINGDalian, Liaoning, 116001, China
-
Fudan University Affiliated Obstetrics and Gynecology Hospital
RECRUITINGShanghai, Shanghai Municipality, 214432, China
-
Fudan University Shanghai Cancer Center
RECRUITINGShanghai, Shanghai Municipality, 200032, China
-
Fujian Cancer Hospital
RECRUITINGFuzhou, Fujian, 350014, China
-
Guangxi Medical University Affiliated Cancer Hospital
RECRUITINGGuilin, Guangxi, 530021, China
-
Harbin Medical University Affiliated Cancer Hospital
RECRUITINGHa’erbin, Heilongjjiang, 150081, China
-
Henan Cancer Hospital
RECRUITINGZhengzhou, Henan, 450003, China
-
Hubei Cancer Hospital
RECRUITINGWuhan, Hubei, 430079, China
-
Jiangxi Maternal and Child Health Hospital
RECRUITINGNanchang, Jiangxi, 330006, China
-
Jining First People's Hospital
RECRUITINGJining, Shandong, 272002, China
-
Shandong First Medical University Affiliated Cancer Hospital
RECRUITINGJinan, Shandong, 250117, China
-
Shanxi Cancer Hospital
RECRUITINGTaiyuan, Shanxi, 030013, China
-
Sichuan University West China Second Hospital
RECRUITINGChengdu, Sichuan, 610044, China
-
Southeast University Affiliated Zhongda Hospital
RECRUITINGNanjing, Jiangsu, 210009, China
-
The Fifth Medical Center of the General Hospital of the People's Liberation Army of China
RECRUITINGBeijing, Beijing Municipality, 222002, China
-
The First Affiliated Hospital of Henan University of Science and Technology
RECRUITINGLuoyang, Henan, 450052, China
-
The First Affiliated Hospital of Xi'an Jiaotong University
RECRUITINGXi’an, Shanxi, 710061, China
-
Tianjin Cancer Hospital
RECRUITINGTianjin, Tianjin Municipality, 300181, China
-
Xiangya Second Hospital of Central South University
RECRUITINGChangsha, Hunan, 410012, China
-
Yibin Second People's Hospital
RECRUITINGYibin, Sichuan, 644002, China
-
Yun Cancer Hospital
RECRUITINGKunming, Yunnan, 650118, China
-
Zhejiang Cancer Hospital
RECRUITINGHangzhou, Zhejiang, 310005, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Hormone-Blocking drug boost chemo against cervical cancer?
- What does a healthy mouth mean for people with disabilities?
- Hidden toll of routine ICU procedure revealed: suctioning may spike pain and stress
- New drug duo takes on recurrent brain cancer
- Could a Two-Drug combo outsmart advanced cervical cancer?
- Spinach showdown: does how It's grown affect your blood pressure?